Pfizer wastes no time touting Celebrex
101354
A day after Whitehouse Station-based Merck abruptly withdrew from the market Vioxx, its blockbuster arthritis drug, Pfizer yesterday moved to promote Celebrex, its competing medicine.
550447
GAITHERSBURG, Maryland  - Pfizer Inc.'s pain reliever Celebrex should be approved for treating rheumatoid arthritis in children despite uncertainty about the risks of long-term use, U.S. advisers said on Wednesday.
196262
Some analysts are betting Pfizer Inc.  won't have to withdraw its arthritis drug Celebrex but they do  expect sales to fall after a study of the drug in cancer  patients showed it increased the risk of heart attacks.
391949
U.S. drug reviewers have questioned Pfizer Inc.'s  data showing the pain reliever Celebrex was as effective as an older drug in treating juvenile rheumatoid arthritis, a summary released on Tuesday said.
169285
A study of the arthritis drug Celebrex made more than four years ago by Pfizer Inc. casts doubt on the company's insistence that it had no hint of the drug's potential heart and stroke risks until recently.-The Washington Post
357920
Pfizer Inc. on Friday said patients  taking its blockbuster arthritis drug Celebrex in a long-term  cancer-prevention trial had more than twice the number of fatal  or non-fatal heart attacks as those taking a placebo.
459276
Pfizer said today that it would sponsor a major clinical trial of Celebrex, its prescription arthritis pain medication, to further assess the cardiovascular safety of the drug.
421539
This morning, Pfizer (nyse: PFE - news - people ) announced that it had received data from two long-term studies in using its arthritis drug Celebrex to prevent cancer.
202222
Stocks were little changed on Friday,  recovering after a sharp early drop on news from Pfizer Inc.  PFE.N that patients in a study showed an increased risk of  heart attacks after taking its popular Celebrex drug.
635918
No. 1 drugmaker to end marketing push after study points to higher risk of heart attack, stroke. NEW YORK (CNN) - Under pressure from regulators, Pfizer has agreed to limit advertising of Celebrex after a
481067
Pharmaceutical giant Pfizer Inc. will announce plans for a large-scale clinical trial of the ability of blockbuster drug Celebrex to prevent heart attacks and strokes in patients with cardiovascular disease, the Wall Street Journal reported on Monday.
114399
Pfizer Inc., the world&#39;s biggest drugmaker, defended its painkiller Celebrex after a researcher&#39;s suggestion the medication may be linked to heart risks sent the stock down as much as 8.3 percent.
688234
NEW YORK -- Drug maker Pfizer said yesterday it would immediately stop advertising its best-selling arthritis pain reliever Celebrex to consumers after a study showed high doses of it were associated with an increased heart attack risk.
130664
The drug maker stops advertising Celebrex, but says it won&#39;t pull the drug from the market. Oil dips below $46 per barrel. Stocks are indicated to open higher today, but trading could be subdued this holiday-shortened week.
252263
Pfizer Inc. on Friday said patients taking its blockbuster arthritis drug Celebrex in a long-term cancer-prevention trial had more than twice the number of fatal or non-fatal heart attacks as those taking a placebo.
84184
As the Food and Drug Administration prepares to make recommendations about Pfizer&#39;s (PFE:NYSE - news - research) Celebrex, the companies that ultimately pay for the drug aren&#39;t leaping to conclusions merely because one recent study showed patients taking
90113
The Canadian health department said on Thursday that it had determined that no regulatory intervention was needed on Pfizer Inc.&#39;s arthritis drug Celebrex after a report in a Canadian newspaper linked it to 14 deaths.